Vomiting: Labs, Diagnosis, and Next Steps

Why Vomiting Happens: The Neurophysiology

Vomiting is a coordinated reflex controlled by the nucleus tractus solitarius and the chemoreceptor trigger zone (CTZ) in the area postrema of the medulla. These centers receive input from at least four distinct pathways: vagal and sympathetic afferents from the GI tract, vestibular signals, higher cortical input, and circulating toxins or drugs that cross the blood-brain barrier at the CTZ [1]. Understanding which pathway is activated guides both the diagnostic workup and the choice of anti-emetic.

The American Gastroenterological Association (AGA) classifies vomiting by duration. Acute vomiting lasts fewer than 7 days and is most often caused by infections, medications, or toxin exposure. Chronic vomiting persists beyond one month and points toward motility disorders, metabolic disease, or structural pathology [2]. A 2021 systematic review in Gastroenterology (N=4,287 patients across 18 studies) found that the most frequent final diagnoses in adults presenting with unexplained chronic nausea and vomiting were gastroparesis (28%), functional dyspepsia (24%), and cyclic vomiting syndrome (12%) [3]. The distinction between acute and chronic changes the lab panel, the imaging approach, and the urgency of subspecialty referral.

Medications account for a significant share of acute cases. Opioids activate mu-receptors in the CTZ directly. Chemotherapy agents damage enterochromaffin cells in the gut mucosa, triggering massive serotonin (5-HT3) release along vagal afferents. GLP-1 receptor agonists like semaglutide slow gastric emptying, with nausea reported in 44% and vomiting in 24.8% of participants receiving semaglutide 2.4 mg in the STEP-1 trial (N=1,961) [4].

The Initial Lab Workup

A basic metabolic panel (BMP) is the single most important first test because it reveals both consequences of vomiting and potential causes simultaneously. The BMP captures sodium, potassium, chloride, bicarbonate, BUN, creatinine, and glucose. Repeated vomiting depletes hydrochloric acid from the stomach, leading to hypochloremic metabolic alkalosis with hypokalemia, a pattern so characteristic that its presence on labs can confirm clinically significant volume loss before physical exam signs appear [5].

The recommended initial panel for any adult presenting with vomiting beyond 24 hours includes:

• Basic metabolic panel (electrolytes, renal function, glucose)
• Hepatic function tests (AST, ALT, alkaline phosphatase, bilirubin)
• Lipase (to screen for pancreatitis)
• Complete blood count (infection, anemia from GI blood loss)
• Urinalysis (ketonuria signals starvation ketosis; UTI can cause vomiting)
• Beta-hCG (all women of reproductive age, regardless of stated contraceptive use)

The American College of Emergency Physicians (ACEP) clinical policy on nausea and vomiting specifically recommends, "Serum lipase should be obtained in patients with vomiting and epigastric or periumbilical pain, as pancreatitis is a commonly missed diagnosis in the emergency department" [6]. A lipase level greater than three times the upper limit of normal has a sensitivity of 82% to 100% for acute pancreatitis [7].

Thyroid-stimulating hormone (TSH) belongs on the expanded panel when vomiting is chronic or recurrent. Both thyrotoxicosis and severe hypothyroidism can present with persistent vomiting. Hyperthyroidism causes vomiting in up to 44% of patients with thyroid storm [8]. Serum calcium is another second-tier test: hypercalcemia above 12 mg/dL commonly produces nausea and vomiting through direct effects on smooth muscle contractility and central chemoreceptor activation.

When Imaging Is Needed

Not every patient who vomits needs imaging. The decision depends on the clinical picture after labs return. A plain abdominal radiograph (KUB) is a reasonable first step when obstruction is suspected, showing air-fluid levels and dilated bowel loops with a sensitivity of approximately 77% for small bowel obstruction [9]. CT abdomen and pelvis with IV contrast is the definitive study when mechanical obstruction, perforation, or an intra-abdominal mass is on the differential. Its sensitivity for small bowel obstruction exceeds 94% [9].

Upper endoscopy (EGD) is indicated when vomiting is accompanied by hematemesis, persistent dysphagia, or weight loss exceeding 5% of body weight. The ACG clinical guideline on gastroparesis recommends EGD as a first step to exclude mechanical obstruction before proceeding to motility testing [10]. A head CT or MRI enters the picture when vomiting co-occurs with headache, papilledema, focal neurologic findings, or altered consciousness, as posterior fossa tumors and elevated intracranial pressure can present with vomiting as the dominant symptom.

The 4-hour solid-phase gastric emptying study (GES) remains the gold standard for diagnosing gastroparesis. The patient eats a standardized radiolabeled egg-white meal, and gamma camera imaging quantifies gastric retention at 1, 2, and 4 hours. Retention of more than 10% at 4 hours confirms delayed gastric emptying [10]. A 2008 multicenter study published in the American Journal of Gastroenterology (N=319) established these reference values and found that the 4-hour measurement alone correctly classified 83% of patients, while the 2-hour measurement alone missed 29% of delayed-emptying cases [11].

Red Flags That Demand Urgent Evaluation

Some vomiting presentations require same-day emergency evaluation. Do not wait for outpatient workup when any of these features are present.

Hematemesis or coffee-ground emesis signals upper GI bleeding. A retrospective cohort study of 1,882 patients presenting to UK emergency departments with upper GI bleeding found a 30-day mortality of 8.6%, with delayed endoscopy beyond 24 hours associated with worse outcomes in hemodynamically unstable patients [12].

Bilious (green) vomiting with severe abdominal pain raises concern for small bowel obstruction or mesenteric ischemia. The abdominal pain of mesenteric ischemia is classically described as "pain out of proportion to exam." A serum lactate above 2.0 mmol/L in this context has a sensitivity of 96% for intestinal ischemia but a specificity of only 38%, meaning a normal lactate is reassuring while an elevated one demands CT angiography [13].

Projectile vomiting without nausea points toward increased intracranial pressure. This pattern is most ominous in adults when it occurs upon waking and worsens over days. Neck stiffness combined with vomiting and fever requires emergent lumbar puncture to rule out meningitis.

Signs of severe dehydration include sunken eyes, absent skin turgor, tachycardia with systolic blood pressure below 90 mmHg, and urine output under 0.5 mL/kg/hr. Pediatric guidelines from the WHO define severe dehydration as fluid loss exceeding 9% of body weight, but adult thresholds are less standardized [14]. BUN-to-creatinine ratio above 20:1 on the BMP suggests prerenal azotemia from volume depletion.

Treating the Vomiting Itself

Anti-emetics work on different receptor systems, and matching the drug to the mechanism improves efficacy while reducing unnecessary side effects. The BMJ Best Practice guideline on nausea and vomiting states, "Empiric anti-emetic therapy should target the most likely pathophysiological mechanism rather than applying a one-size-fits-all approach" [15].

Serotonin (5-HT3) antagonists like ondansetron are first-line for most acute presentations. Ondansetron 4 mg IV or oral dissolving tablet works within 15 to 30 minutes. A 2014 Cochrane review (N=1,366 across 6 trials) found ondansetron superior to metoclopramide for acute gastroenteritis-related vomiting, with a number needed to treat (NNT) of 5 to prevent one additional episode of vomiting [16].

Dopamine (D2) antagonists include metoclopramide and prochlorperazine. Metoclopramide 10 mg IV has the added benefit of being prokinetic, making it particularly useful when gastroparesis is suspected. The FDA limits metoclopramide use to 12 weeks due to the risk of tardive dyskinesia, which occurs in roughly 1% to 10% of patients on chronic therapy [17].

NK-1 receptor antagonists like aprepitant are reserved primarily for chemotherapy-induced nausea and vomiting (CINV). The combination of aprepitant, ondansetron, and dexamethasone reduced vomiting in the first 120 hours post-chemotherapy by 20 percentage points compared to ondansetron and dexamethasone alone in highly emetogenic regimens [18].

Anticholinergics and antihistamines (scopolamine patch, meclizine, dimenhydrinate) target vestibular-mediated vomiting. These are first-line for motion sickness and labyrinthitis but cause sedation and dry mouth that limit their use in other settings.

For refractory cases, dronabinol (synthetic THC) and olanzapine have emerging evidence. A randomized trial published in the New England Journal of Medicine (N=380) found that olanzapine 10 mg daily was superior to placebo for preventing CINV when added to standard triple therapy [19].

Fluid and Electrolyte Correction

Replacing what vomiting takes away is as important as stopping the vomiting itself. Oral rehydration is sufficient for mild dehydration when the patient can tolerate sips. The WHO oral rehydration solution (ORS) formula (sodium 75 mmol/L, glucose 75 mmol/L, osmolarity 245 mOsm/L) improves absorption compared to plain water or sports drinks because glucose-sodium cotransport in the jejunum remains intact even during active gastroenteritis [14].

Intravenous fluid resuscitation is indicated when oral intake is not tolerated or when labs show significant electrolyte derangement. Normal saline (0.9% NaCl) at 20 mL/kg bolus followed by maintenance rates corrects volume depletion. Potassium replacement should begin once urine output is confirmed, typically adding 20 to 40 mEq KCl per liter of IV fluid. Hypokalemia below 3.0 mEq/L requires more aggressive repletion because cardiac arrhythmia risk increases substantially at this threshold [5].

Metabolic alkalosis from vomiting is chloride-responsive. Normal saline provides the chloride needed for renal correction of the alkalosis, making it the preferred resuscitation fluid over lactated Ringer's in this specific context. Serial BMPs every 6 to 12 hours guide the pace of correction until potassium exceeds 3.5 mEq/L and bicarbonate falls below 30 mEq/L.

Outpatient Follow-Up and Monitoring

Patients discharged from the emergency department or urgent care after a vomiting episode need clear follow-up instructions. A primary care visit within 3 to 5 days is appropriate for resolved acute gastroenteritis. Gastroenterology referral within 2 weeks is warranted when vomiting recurs, when gastroparesis is suspected, or when initial labs reveal unexplained hepatic or pancreatic enzyme elevation.

Cyclic vomiting syndrome (CVS) deserves special mention because it is frequently misdiagnosed as recurrent gastroenteritis or psychiatric illness. The Rome IV criteria define CVS as at least three discrete episodes of vomiting in the prior year with at least one week between episodes and absence of structural or metabolic disease [20]. The North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) estimates a diagnostic delay of 2.5 years on average. Prophylactic amitriptyline (25 to 75 mg nightly) reduces episode frequency by approximately 70% based on retrospective series [20].

Patients on GLP-1 receptor agonists who develop vomiting should not automatically discontinue the medication. Dose reduction or slower titration resolves symptoms in most cases. The prescribing information for semaglutide recommends holding the dose escalation and maintaining the current dose until symptoms resolve before attempting to increase again [4]. Persistent vomiting beyond 2 weeks on a stable GLP-1 dose, however, warrants a gastroparesis evaluation with a gastric emptying study, as GLP-1 agonists can unmask or worsen pre-existing motility disorders.

Track hydration status at home by monitoring urine color (pale yellow is the target), body weight (daily morning weight to detect fluid shifts), and the ability to keep down at least 1.5 liters of fluid per day. Return to the emergency department if vomiting recurs with hematemesis, if fever exceeds 39°C (102.2°F), if no urine output occurs for 8 or more hours, or if confusion develops.